<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9440284</article-id><article-id pub-id-type="pii">S2589-0042(22)01216-0</article-id><article-id pub-id-type="doi">10.1016/j.isci.2022.104944</article-id><article-id pub-id-type="publisher-id">104944</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Phosphorylation of BRCA1 by ATM upon double-strand breaks impacts ATM function in end-resection: A potential feedback loop</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Qi</surname><given-names>Leilei</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn3" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Chakravarthy</surname><given-names>Reka</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref><xref rid="fn3" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Li</surname><given-names>Monica M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn2" ref-type="fn">5</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Deng</surname><given-names>Chu-Xia</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Li</surname><given-names>Rong</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Hu</surname><given-names>Yanfen</given-names></name><email>huy3@gwu.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn4" ref-type="fn">7</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Anatomy and Cell Biology, the George Washington University, School of Medicine and Health Sciences, Washington DC20037, USA</aff><aff id="aff2"><label>2</label>Department of Biochemistry and Molecular Medicine, the George Washington University, School of Medicine and Health Sciences, Washington DC20037, USA</aff><aff id="aff3"><label>3</label>Cancer Center, Faculty of Health Sciences, University of Macau, Macau, SAR China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>huy3@gwu.edu</email></corresp><fn id="fn1"><label>4</label><p id="ntpara0010">Present address: Department of Dermatology, Columbia University Irving Medical Center, New York, NY10032, USA</p></fn><fn id="fn2"><label>5</label><p id="ntpara0015">Present address: Department of Medicine, School of Medicine, J. Willis Hurst Internal Medicine Residency Program, Emory University, Atlanta, Ga30322, USA</p></fn><fn id="fn3"><label>6</label><p id="ntpara0020">These authors contributed equally</p></fn><fn id="fn4"><label>7</label><p id="ntpara0025">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>15</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>8</month><year>2022</year></pub-date><volume>25</volume><issue>9</issue><elocation-id>104944</elocation-id><history><date date-type="received"><day>15</day><month>4</month><year>2022</year></date><date date-type="rev-recd"><day>25</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 The Authors</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>BRCA1 maintains genome stability by promoting homologous recombination (HR)-mediated DNA double-strand break (DSB) repair. Mutation of mouse BRCA1-S1152, corresponding to an ATM phosphorylation site in its human counterpart, resulted in increased genomic instability and tumor incidence. In this study, we report that BRCA1-S1152 is part of a feedback loop that sustains ATM activity. BRCA1-S1152A mutation impairs recruitment of the E3 ubiquitin ligase SKP2. This in turn attenuates NBS1-K63 ubiquitination by SKP2 at DSB, impairs sustained ATM activation, and ultimately leads to deficient end resection, the commitment step in the HR repair pathway. Auto-phosphorylation of human ATM at S1981 is known to be important for its kinase activation; we mutated the corresponding amino acid residue in mouse ATM (S1987A) to characterize potential roles of mouse ATM-S1987 in the BRCA1-SKP2-NBS1-ATM feedback loop. Unexpectedly, MEFs carrying the ATM-S1987A knockin mutation maintain damage-induced ATM kinase activation, suggesting a species-specific function of human ATM auto-phosphorylation.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">BRCA1-S1152A decreases mouse ATM phosphorylation and activity</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">BRCA1-Skp2-NBS1-ATM forms a feedback loop on ATM phosphorylation and activity</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Mouse ATM-S1987 is not required for ATM phosphorylation and activity</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Biological sciences; Biochemistry; Biochemistry applications</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Biological sciences</kwd><kwd>Biochemistry</kwd><kwd>Biochemistry applications</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: September 16, 2022</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0030">Germ-line mutations in <italic>BRCA1</italic> predispose women to breast and/or ovarian cancer (<xref rid="bib1" ref-type="bibr">Abdulkarim et&#x000a0;al., 2011</xref>). Since the identification of <italic>BRCA1</italic> gene in 1994, molecular studies have established that BRCA1 functions as a tumor suppressor, in large part, through its role in maintaining genome stability by promoting high fidelity, homologous recombination (HR)-mediated repair of DNA double-strand breaks (DSBs) (<xref rid="bib30" ref-type="bibr">Zhang and Powell, 2005</xref>). Extensive characterizations reveal that BRCA1 forms multiple complexes with various DNA repair proteins at different stages of DNA damage response and repair (<xref rid="bib6" ref-type="bibr">Huen et&#x000a0;al., 2010</xref>). It is also well documented that upon DNA damage, BRCA1 protein is rapidly phosphorylated by multiple kinases involved in DNA repair and cell-cycle checkpoint controls such as ATM, CHK2, ATR etc. (<xref rid="bib20" ref-type="bibr">Scully et&#x000a0;al., 1997a</xref>) (<xref rid="bib21" ref-type="bibr">Scully et&#x000a0;al., 1997b</xref>) (<xref rid="bib4" ref-type="bibr">Cortez et&#x000a0;al., 1999</xref>) (<xref rid="bib13" ref-type="bibr">Lee et&#x000a0;al., 2000</xref>). Studies of human cell lines and genetically engineered mouse models showed that several of these phosphorylation sites are important for BRCA1 functions in DNA damage response (DDR). For example, we and others show that CHK2 phosphorylation of human BRCA1-S988 (or its corresponding mouse BRCA1-S971) is important for BRCA1&#x02019;s roles in maintenance of genome stability and promotion of HR-mediated DSB repair (<xref rid="bib13" ref-type="bibr">Lee et&#x000a0;al., 2000</xref>) (<xref rid="bib9" ref-type="bibr">Kim et&#x000a0;al., 2004</xref>) (<xref rid="bib31" ref-type="bibr">Zhang et&#x000a0;al., 2004</xref>) (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). In particular, our published study shows that CHK2 phosphorylation of BRCA1-S971 coordinates end resection, the commitment step in HR pathway, to the S/G2 phases of the cell cycle through an elaborate &#x0201c;automation-like&#x0201d; mechanism (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). However, compared with the extensive characterization of the dynamics of the DDR-induced BRCA1 protein complexes, the functionality of BRCA1 phosphorylation remains incompletely understood. In particular, it is unclear how multiple BRCA1 phosphorylation events by different kinases act in a functionally distinct and concerted manner to regulate its activity in HR-mediated DSB repair.</p><p id="p0035">In response to DNA damage, BRCA1 is phosphorylated by the Ser/Thr protein kinase ATM at multiple serine residues, although the ATM phosphorylation sites mapped <italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> are not completely identical (<xref rid="bib4" ref-type="bibr">Cortez et&#x000a0;al., 1999</xref>). ATM-dependent phosphorylation of human BRCA1-S1189 was initially identified <italic>in&#x000a0;vivo</italic>, but its functional significance was not clear (<xref rid="bib4" ref-type="bibr">Cortez et&#x000a0;al., 1999</xref>). A follow-up study that mutated the corresponding residue in mouse BRCA1 (BRCA1-S1152A) showed that mice with the abrogated ATM phosphorylation site exhibited increased &#x003b3;-irradiation (&#x003b3;IR)-induced tumorigenesis (<xref rid="bib8" ref-type="bibr">Kim et&#x000a0;al., 2009</xref>), suggesting that this evolutionally conserved ATM phosphorylation site in BRCA1 is functionally important and likely plays roles in DDR and DSB repair. However, the molecular mechanism by which this particular ATM phosphorylation site supports BRCA1 function was not understood. Specifically, it is not known whether this phosphorylation event influences BRCA1 activity through a different mechanism from the aforementioned CHK2-mediated phosphorylation event (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>).</p><p id="p0040">To elucidate the functional impact of ATM phosphorylation of BRCA1-S1152 on HR-mediated DNA DSB repair, we used mouse embryonic fibroblasts (MEFs) derived from BRCA1-S1152A KI mutant embryos in a comparative study with those carrying the S971A mutation. We found that similar to what has been observed in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEFs, abrogation of BRCA1-S1152 phosphorylation impaired end resection without affecting the assembly of end resection complex MRE11, RAD50, and CtIP at DSBs. However, unlike <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEFs, <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells were defective in sustaining the ATM kinase activity, suggesting a potential positive feedback loop. In addition, our study also shed light on a species-specific function of ATM auto-phosphorylation. Thus, our results provide compelling evidence for distinct and nuanced roles of different BRCA1 phosphorylation events in orchestrating end resection in HR-mediated DSB repair.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Abrogation of ATM phosphorylation on mouse BRCA1-Ser1152 impairs end resection</title><p id="p0045">To determine whether phosphorylation of mouse BRCA1-S1152 impacts end resection in HR-mediated DSB repair, two pairs of MEFs (<italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>) from independent breeding were immortalized. Upon confirming that the BRCA1 expression levels and cell cycle distributions were compatible between WT and mutant MEFs (data not shown and <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>), we examined the impact of BRCA1-S1152A mutation on end resection and assembly of protein complexes involved in end resection. First, we used BrdU-dependent laser microirradiation, followed by indirect immunofluorescence (IF) staining of RAD51 (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). RAD51 is one of the key players in the HR-mediated DSB repair pathway. RAD51 is recruited to DSBs to &#x0201c;coating&#x0201d; single-stranded DNA (ssDNA) generated from end resection, a commitment step that serves as an initiation of the HR pathway. Therefore, RAD51 recruitment to laser-induced DSBs signifies successful end resection. As demonstrated by our published work (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>), the experimental condition used in this assay limits laser-induced DSBs to cells at the S/G2 phases of the cell cycle, when HR-mediated DSB repair normally occurs (also see &#x0201c;<xref rid="sec4" ref-type="sec">STAR Methods</xref>&#x0201d; for details).</p><p id="p0050">Both <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells were subject to BrdU-dependent laser microirradiation. Presence of RAD51 at DSBs at 10, 30, and 60&#x000a0;min after microirradiation was visualized by indirect immunofluorescence (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A top panel). &#x003b3;H2AX (green stripes) serves as a readout for microirradiation-generated DSBs, whereas RAD51 (red stripes) indicates execution of end resection at DSBs. The percentage of RAD51<sup>+</sup>/&#x003b3;H2AX<sup>+</sup> cells reflects the overall efficiency of end resection after microirradiation (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A graph at the bottom). End resection efficiency was significantly lower in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs versus <italic>Brca1</italic><sup><italic>WT</italic></sup> MEFs at the two early time points (10 and 30&#x000a0;min), suggesting a delay or lower efficiency in DSB repair.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Abrogation of ATM phosphorylation on BRCA1-S1152 impairs end resection</p><p>(A) RAD51 recruitment upon microirradiation. RAD51 laser stripes (red) and &#x003b3;H2AX (green) from S/G2 cells at 10, 30, and 60&#x000a0;min after microirradiation. Scale bar, 10&#x000a0;&#x003bc;m. Bar graph shows quantification of laser stripes. Average from 6 independent experiments. 10&#x000a0;min (n&#x000a0;= 248 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 165 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 7.58164&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;5</sup>); 30&#x000a0;min (n&#x000a0;=&#x000a0;201 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 140 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.026263168); 60&#x000a0;min (n&#x000a0;= 290 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 292 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.09250862).</p><p>(B) Detection of ssDNA upon microirradiation. BrdU (ssDNA) stripes (red) and &#x003b3;H2AX (green) from total cell population at 10, 30, and 60&#x000a0;min time points after microirradiation. Scale bar, 10&#x000a0;&#x003bc;m. Bar graph shows quantification of laser stripes. Average from 3 independent experiments. 10&#x000a0;min (n&#x000a0;= 594 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 803 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.003895929); 30&#x000a0;min (n&#x000a0;= 529 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 809 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.002853738); 60&#x000a0;min (n&#x000a0;= 653 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 912 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.003046438).</p><p>(C) Phosphorylation of CHK1and RPA32, but not of H2AX, is impaired in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs 10 and 60&#x000a0;min after IR (10&#x000a0;Gy).</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0055">Besides RAD51 recruitment to DSBs, detection of BrdU-labeled ssDNA can also serve as a readout of successful end resection (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). Under this particular assay condition (see <xref rid="sec4" ref-type="sec">STAR Methods</xref>), BrdU serves a different purpose. Laser microirradiation was conducted in a BrdU-independent manner to ensure that BrdU positivity reflects only efficiency of end resection, not that of DSB generation. Importantly, BrdU incorporated into DNA is detectable with BrdU antibodies only when DNA is in single-stranded form. As a result, BrdU immunostaining could detect ssDNA generated by end resection, but not their double-stranded counterpart (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B). Consistent with the findings from the RAD51-based assay (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A), the percentage of BrdU<sup>+</sup>/&#x003b3;H2AX<sup>+</sup> was also lower in mutant MEFs than their WT counterpart (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B graph at bottom panel). Because <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs have very similar cell-cycle distribution (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>), the difference in BrdU stripes reflects intrinsic difference in end resection efficiency upon microirradiation, rather than difference in percentage of S/G2 cells. Taken together, these results clearly support the notion that BRCA1-S1152 phosphorylation is required for efficient end resection.</p><p id="p0060">To further corroborate impaired end resection in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells, we assessed IR-induced phosphorylation of CHK1-S345 and RPA2-S4/8, which occurs downstream of end resection in the HR pathway. The levels of CHK1-S345 and RPA2-S4/8 phosphorylation correlate with end resection as well. Consistent with the findings from the laser microirradiation experiments, phosphorylation of CHK1-S345 and RPA2-S4/8 10 and 60&#x000a0;min after &#x003b3;-irradiation was significantly weaker in mutant MEF cells than their WT control (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C).</p></sec><sec id="sec2.2"><title>Abrogation of phosphorylation on mouse BRCA1-S1152 has differential impact on assembly of MRN, CtIP, and 53BP1</title><p id="p0065">To elucidate the mechanism underlying impaired end resection in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells, we examined assembly of MRE11, NBS1, CtIP, and 53BP1 at DSBs, as these proteins have been shown to play important roles in end resection and regulate choice of repair pathways between HR and non-homologous end-joining (NHEJ). Microirradiation followed by indirect immunofluorescence showed that recruitment of MRE11, CtIP, and 53BP1 at DSBs was statistically indistinguishable between <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells at all time points after microirradiation (<xref rid="fig2" ref-type="fig">Figures&#x000a0;2</xref>A&#x02013;2C). In contrast, recruitment of NBS1 at DSBs was consistently slower in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells than their WT control at all three time points (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). This is different from abrogation of CHK2 phosphorylation of mouse BRCA1-S971, which does not affect assembly of MRE11-RAD50-NBS1, CtIP, or 53BP1 (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). Our previous work showed physical association between BRCA1 and NBS1 (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). We therefore used coimmunoprecipitation to compare the affinity of human WT and mutant BRCA1 (S1189A and S988A corresponding to mouse S1152A and S971A, respectively) for NBS1, before and after &#x003b3;-irradiation. Flag-tagged human BRCA1 was transiently expressed in HEK293T cells and immunoprecipitated with an anti-Flag antibody. Although WT and BRCA1-S988A retained the binding affinity for NBS1 in irradiated cells, much less NBS1 was coimmunoprecipitated with BRCA1-S1189A after &#x003b3;-irradiation versus prior (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E). Collectively, these data suggest a distinct role of ATM phosphorylation of BRCA1 in NBS1 recruitment during end resection.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Abrogation of ATM phosphorylation on BRCA1-S1152 affects assembly of NBS1 but not on the recruitment of MRE11/CtIP/53BP1 upon DNA damage</p><p>Recruitment of MRE11 (A), CtIP (B), 53BP1 (C), and NBS1 (D)&#x000a0;after microirradiation in BRCA1 WT and S1152A MEF cells. Laser stripes of indicated proteins (red) and &#x003b3;H2AX (green) from S/G2 cells at 10, 30, and 60&#x000a0;min time points. Scale bar, 10&#x000a0;&#x003bc;m. Bar graph shows quantification of laser strips. Average from 3 to 4 independent experiments. For MRE11: 10&#x000a0;min&#x000a0;(n&#x000a0;= 452 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 437 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.1176); 30&#x000a0;min (n&#x000a0;= 405 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 433 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.0695); 60&#x000a0;min (n&#x000a0;= 511 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 676 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.1299). These data are from 3 independent experiments. For 53BP1: 10&#x000a0;min (n&#x000a0;= 534 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 687 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.007104); 30&#x000a0;min (n&#x000a0;= 436 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 407 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.170465); 60&#x000a0;min (n&#x000a0;= 543 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 386 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.267004). The data are from 4 independent experiments. For CtIP: 10&#x000a0;min (n&#x000a0;= 147 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 170 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.024461); 30&#x000a0;min (n&#x000a0;= 115 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 215 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.251565); 60&#x000a0;min (n&#x000a0;= 103 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 214 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.178625). The data are from 4 independent experiments. For NBS1, 10&#x000a0;min (n&#x000a0;= 125 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 102 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.002956746); 30&#x000a0;min (n&#x000a0;= 203 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 174 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.000222756); 60&#x000a0;min (n&#x000a0;= 159 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 165 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.002122252).</p><p>(E) Interaction of BRCA1 with RAD51 and CtIP is comparable among Flag-tagged human BRCA1 (WT, S1189A, and S988A) as shown in coimmunoprecipitation assay in HEK293 cells. However, interaction between NBS1 and Flag-BRCA1-S1189A is reduced after IR.</p></caption><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec2.3"><title>Abrogation of phosphorylation on mouse BRCA1-S1152 impairs ATM phosphorylation</title><p id="p0070">We examined impact of abrogation of mouse BRCA1-S1152 phosphorylation on ATM phosphorylation and activation, a molecular event upstream of end resection in HR-mediated DSB repair. Phosphorylation of human ATM-S1981, which corresponds to mouse ATM-S1987, has been well established as a marker for human ATM kinase activation (<xref rid="bib2" ref-type="bibr">Bakkenist and Kastan, 2003</xref>) (<xref rid="bib22" ref-type="bibr">Shiloh and Ziv, 2013</xref>) (<xref rid="bib3" ref-type="bibr">Blackford and Jackson, 2017</xref>) (<xref rid="bib12" ref-type="bibr">Lee and Paull, 2021</xref>). One human anti-ATM-pS1981 antibody is commonly used to detect mouse ATM activation (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>) (<xref rid="bib23" ref-type="bibr">Stracker et&#x000a0;al., 2007</xref>) (<xref rid="bib24" ref-type="bibr">Tian and Mao, 2009</xref>) (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>) (<xref rid="bib14" ref-type="bibr">Lim et&#x000a0;al., 2013</xref>), whereas another published antibody raised against mouse ATM-pS1987 is no longer available (Manuela Pellegrini and Andre Nussenzweig, personal communication) (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>). We therefore used the human anti-ATM-pS1981 antibody in a time course study of ATM phosphorylation/activation following &#x003b3;-irradiation of BRCA1 WT and mutant MEFs (<italic>Brca1</italic><sup><italic>WT</italic></sup>, <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, and <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup>). Consistent with our previously published work (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>), abrogation of CHK2 phosphorylation on BRCA1-S971 did not affect IR-induced ATM phosphorylation (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A bottom panel). In contrast, ATM phosphorylation upon &#x003b3;-irradiation was significantly impaired in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A top panel). To ascertain that the impaired ATM phosphorylation in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs was indeed due to the loss of BRCA1 function, mouse WT BRCA1 was overexpressed in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells. Expression of exogenous mouse WT BRCA1 restored IR-induced ATM phosphorylation to the levels comparable to that in parental WT MEFs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B left panel), corroborating a direct causal relationship between mouse BRCA1-S1152A and ATM phosphorylation. Intriguingly, overexpression of human WT BRCA1 did not restore ATM phosphorylation in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B right panel), suggesting human and mouse BRCA1 proteins are not interchangeable in this functional readout.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Abrogation of ATM phosphorylation on BRCA1-S1152 affects the kinetics of ATM activation in response to DNA damage</p><p>(A) The kinetics of ATM phosphorylation/activation is affected in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells, but not in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEF cells, compared with <italic>Brca1</italic><sup><italic>WT</italic></sup> cells. Overexpression of mouse WT BRCA1 (B top), but not human WT BRCA1 (B bottom), in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells restores ATM activation. The ATM doublet on the blot appears only when samples are loaded near the edge of a gel. This position effect is not fully understood.</p><p>(C) Phosphorylation of ATM substrates in <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells. CHK2 phosphorylation can be detected using CHK2 antibody as phosphorylation caused upshift of CHK2 position.</p><p>(D) Recruitment of phospho-ATM is partially impaired in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF but not in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEF. (E) Phospho-ATM laser stripes (red) and &#x003b3;H2AX (green) from S/G2 cells. Scale bar, 10&#x000a0;&#x003bc;m. For S1152A pair: 10&#x000a0;min (n&#x000a0;= 124 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 138 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.03552); 30&#x000a0;min (n&#x000a0;= 125 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 127 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;=&#x000a0;0.01515); 60&#x000a0;min (n&#x000a0;= 101for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 100 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.01803). Bar graph is average of 4 independent experiments. For S971A pair: 10&#x000a0;min (n&#x000a0;= 260 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 188 for <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup>, p&#x000a0;= 0.451564); 30&#x000a0;min (n&#x000a0;= 308 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 302 for <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup>, p&#x000a0;= 0.192651); 60&#x000a0;min (n&#x000a0;= 290 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 107 for <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup>, p&#x000a0;= 0.17004). Bar graph is average of 2 independent experiments.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0075">Next, we investigated whether impaired ATM phosphorylation in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells affects ATM kinase activity. To this end, we assessed phosphorylation of several known ATM substrates upon &#x003b3;-irradiation, including SMC1, p53, KAP1, and CHK2. Phosphorylation of SMC1 and tumor suppressor p53 was not affected and that of KAP1 was only mildly decreased in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). In contrast, phosphorylation of CHK2 was substantially reduced in mutant MEFs at all time points examined (shifted bands in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). These results suggest that the impact of ATM phosphorylation on its kinase activity is substrate dependent in MEFs.</p><p id="p0080">Lastly, we examined how impaired ATM phosphorylation affects its own recruitment to DSBs. BRCA1 WT and mutant MEFs were subject to laser microirradiation followed by indirect immunofluorescence using the anti-human ATM-pS1981 antibody (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). Laser microirradiation was conducted in a BrdU-dependent manner to capture initial DDR steps in S/G2 cells. Our results showed that the presence of phosphorylated ATM at DSBs was reduced in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> versus <italic>Brca1</italic><sup><italic>WT</italic></sup> MEFs at all three time points (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D, 10, 30, and 60&#x000a0;min). In contrast, <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEFs and their WT counterparts exhibited no difference in recruitment of phosphorylated ATM at DSBs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>E), indicating that BRCA1-S1152 phosphorylation is uniquely important for recruitment of phosphorylated ATM to DSBs.</p></sec><sec id="sec2.4"><title>&#x0201c;SKP2-NBS1 ubiquitination-ATM activation&#x0201d; circuit is impaired in <italic>Brca1</italic><sup><italic>S1152/S1152A</italic></sup> MEF cells</title><p id="p0085">It was previously reported that the E3 ubiquitin ligase SKP2 integrates ATM activation in HR-mediated DNA repair through its K63-linked ubiquitination of NBS1 (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>). The connection between ATM and MRN complex is thought to be a central functional link during ATM activation (<xref rid="bib22" ref-type="bibr">Shiloh and Ziv, 2013</xref>). Unlike K48-linked ubiquitination, K63-linked ubiquitination does not mediate protein degradation. Rather, it is involved in protein-protein interaction (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>). Reduced NBS1-K63 ubiquitination leads to weakened interaction between ATM and NBS1, which in turn results in deficient ATM activation (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>). Our own published results also established that SKP2 interacts with BRCA1 in cell extract and at DSBs (<xref rid="bib15" ref-type="bibr">Lu et&#x000a0;al., 2012</xref>) (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). We therefore speculated that BRCA1-S1152A might weaken interaction between BRCA1 and SKP2, which could account for reduced recruitment of NBS1 (<xref rid="fig2" ref-type="fig">Figures&#x000a0;2</xref>D and 2E) and activation of ATM (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>). Due to lack of quality SKP2 antibody that recognizes mouse SKP2 in IP-Western assay (data not shown), we examined interaction between human Flag-BRCA1 and endogenous SKP2 in HEK293T cells. Flag-BRCA1 (WT, S988A, S1189A) was immunoprecipitated with an anti-Flag antibody, and the level of associated endogenous SKP2 was compared. Our results showed that interaction between BRCA1-S1189A (corresponding to mouse BRCA1-S1152A) and SKP2 was significantly reduced following &#x003b3;-IR, whereas that of WT and BRCA1-S988A was either not affected or even slightly increased (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). In addition, we found by laser microirradiation/IF that recruitment of SKP2 to DSBs was much slower in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs than their WT counterparts (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>B). Together these data support the notion that BRCA1-S1152 is important for BRCA1-dependent SKP2 recruitment to DSB repair events.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Abrogation of ATM phosphorylation on BRCA1-S1152 reduces SKP2 recruitment and ATM-NBS1 interaction upon DNA damage</p><p>(A) Coimmunoprecipitation shows reduced interaction between BRCA1-S1198A and SKP2 in HEK293 cells.</p><p>(B) Recruitment of SKP2 upon microirradiation. SKP2 laser stripes (green) and &#x003b3;H2AX (red) at 10, 30, and 60&#x000a0;min time&#x000a0;points are shown. Scale bar, 10&#x000a0;&#x003bc;m. Bar graph below is quantification of three independent experiments. For 10&#x000a0;min (n&#x000a0;= 326 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 351 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.007656); 30&#x000a0;min (n&#x000a0;= 336 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 427 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.009519); 60&#x000a0;min (n&#x000a0;= 336 for <italic>Brca1</italic><sup><italic>WT</italic></sup> and n&#x000a0;= 380 for <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup>, p&#x000a0;= 0.009258).</p><p>(C) Immunoprecipitation of endogenous NBS1 shows reduced K63-linked ubiquitination of NBS1 in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells, but not in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEF cells, in response to DNA damage.</p><p>(D) Coimmunoprecipitation shows reduced interaction between NBS1 and ATM upon DNA damage in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells but not in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEF cells.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0090">Next, we determined whether SKP2-mediated NBS1-K63 ubiquitination is affected in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs. Endogenous NBS1 was immunoprecipitated, and its K63-linked ubiquitination was detected using an antibody against K63-ubiquitination. Consistent with the published findings, NBS1-K63 ubiquitination in <italic>Brca1</italic><sup><italic>WT</italic></sup> cells was significantly increased upon &#x003b3;-IR (compare lane 1 and 2 in <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). In contrast, the level of NBS1-K63 ubiquitination in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells was noticeably lower than that in the WT control (compare lane 2 and 4 in <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). As a comparison, there was no decrease in NBS1-K63 ubiquitination in <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> cells in response to &#x003b3;-IR (lanes 5&#x02013;8 in <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). Thus, BRCA1-S1152 plays a unique role in facilitating NBS1-K63 ubiquitination.</p><p id="p0095">Lastly, we examined the impact of BRCA1-S1152A on the interaction between NBS1 and phospho-ATM. As&#x000a0;expected, co-IP showed that in <italic>Brca1</italic><sup><italic>WT</italic></sup> MEFs, &#x003b3;-IR resulted in more ATM phosphorylation and NBS1-associated phospho-ATM (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D). However, much less NBS1-associated phospho-ATM was detected in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> cells compared with their WT counterparts (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D; left panel). Of note, <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEFs did not display a similar decrease in NBS1-associated phospho-ATM (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D; right panel), supporting a unique role of BRCA1-S1152 in influencing the link between ATM and the MRN complex. Taken together, our data suggest that BRCA1-S1152 facilitates positive feedback in a previously established functional circuit that involves SKP2-NBS1 ubiquitination-ATM activation (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>).</p></sec><sec id="sec2.5"><title>Abrogation of mouse ATM-S1987 phosphorylation does not impact ATM kinase activity</title><p id="p0100">It has been well documented that phosphorylation of human ATM-S1981, which corresponds to mouse ATM-S1987, is both a marker and prerequisite for its kinase activation (<xref rid="bib2" ref-type="bibr">Bakkenist and Kastan, 2003</xref>) (<xref rid="bib12" ref-type="bibr">Lee and Paull, 2021</xref>). Of note, the amino acid sequences flanking mouse ATM-S1987 and human ATM-S1981 are not identical (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A). Furthermore, the role of mouse ATM-S1987 phosphorylation in HR-mediated repair remains controversial (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>) (<xref rid="bib12" ref-type="bibr">Lee and Paull, 2021</xref>). The same phospho-Ser antibody raised against human ATM-pS1981 has been commonly used as a marker for mouse ATM activation (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>) (<xref rid="bib23" ref-type="bibr">Stracker et&#x000a0;al., 2007</xref>) (<xref rid="bib24" ref-type="bibr">Tian and Mao, 2009</xref>) (<xref rid="bib27" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>) (<xref rid="bib14" ref-type="bibr">Lim et&#x000a0;al., 2013</xref>). To determine whether &#x003b3;IR-induced ATM phosphorylation as detected by the anti-human phospho-ATM antibody was indeed due to ATM-S1987 phosphorylation, we generated ATM-S1987A knockin (KI) mutation in <italic>Brca1</italic><sup><italic>WT</italic></sup> MEFs using CRISPR/Cas9 genome editing method (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). In the process of generating <italic>Atm</italic><sup><italic>S1987A/S1987A</italic></sup> KI MEFs, we also obtained ATM knockout (KO) clones, due to indels in the sgRNA-targeted DNA region.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Mouse ATM Ser1987 is not required for ATM kinase activity</p><p>(A) Predicted human and mouse ATM recognizing sites for phospho-ATM antibody.</p><p>(B) DNA sequence of CRISPR/Cas9-mediated ATM-S1987A knockin (KI) and ATM knockout (KO) clones derived from wild-type MEF.</p><p>(C) Activation of ATM kinase activity 45&#x000a0;min after IR in ATM WT, KI, and KO MEF cells. Note that CHK2 phosphorylation caused upshift of CHK2 from a discrete band to cluster of bands.</p></caption><graphic xlink:href="gr5"/></fig></p><p id="p0105">Two independent KI and KO clones (designated as ATM KI-1, KI-2, KO-1, KO-2, in <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B) and their WT counterpart were compared for ATM phosphorylation and kinase activity (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). To our surprise, ATM phosphorylation in response to &#x003b3;-IR, as detected by the anti-human-ATM-pS1981 antibody, was not affected at all in <italic>Atm</italic><sup><italic>S1987A/S1987A</italic></sup> KI MEFs compared with parental WT cells (compare lanes 7 and 8 with 6 in top panel of <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). In ATM KO MEFs, the total ATM band was absent as expected (lanes 9 and 10 of top second panel in <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). The &#x003b3;IR-induced phospho-ATM band was significantly reduced, although a faint band at the phospho-ATM position could still be detected by the anti-human ATM-pS1981 antibody, suggesting a low level of antibody cross-reactivity (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C top panel, lanes 9 and 10). These&#x000a0;data strongly suggest that, contrary to prevalent assumption, the anti-human-ATM-pS1981 antibody most likely detects mouse ATM phosphorylation independent of S1987. In addition, &#x003b3;IR-induced phosphorylation of ATM kinase substrates, including SMC1, KAP1, CHK2, p53, and H2AX, was as effective in <italic>Atm</italic><sup><italic>S1987A/S1987A</italic></sup> KI MEFs as in WT MEFs (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C lanes 6&#x02013;8), thus supporting the notion that S1987 is not required for ATM kinase activation. In ATM KO MEFs, &#x003b3;IR-induced phosphorylation of KAP1 and CHK2 was barely detectable, whereas that of SMC1 and p53 was reduced as compared with WT MEFs (compare lanes 9 and 10 with 6 in <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). The presence of low level of SMC1 and p53 phosphorylation in the absence of ATM suggests there might be ATM-independent alternative pathways in MEFs to phosphorylate SMC1 and p53. The existence of alternative pathways could also explain that, in <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEFs, decreased ATM phosphorylation/activation impacted CHK2 and KAP1 phosphorylation more significantly than that of SMC1 and p53 (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). Together, the mutational study of ATM-S1987A strongly suggests that anti-human ATM-pS1981 recognizes mouse ATM that is phosphorylated at a site(s) other than ATM-pS1987. Furthermore, ATM-S1987 is not required for mouse ATM activation.</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0110">BRCA1 is phosphorylated at multiple serine residues by various DDR-related kinases following DNA damage. Although this observation was among the earliest documented phenomena in BRCA1 research since the cloning of <italic>BRCA1</italic> gene in 1994, the functional role of these phosphorylation sites remained incompletely understood. This is partly due to the fact that posttranslational modifications including phosphorylation often play a role in fine-tuning one particular aspect of multifunctional proteins such as BRCA1. In particular, it is technically challenging to interrogate the impact of these posttranslational modifications on dynamic and reversible processes such as DNA damage response, where DNA repair machinery is assembled and subsequently dissembled after damage is cleared and before normal cell cycle is resumed.</p><p id="p0115">In this study, we continue our investigation on the role of damage-induced BRCA1 phosphorylation in DDR. We show that abrogation of phosphorylation on mouse BRCA1-S1152, which corresponds to ATM phosphorylation site of human BRCA1-S1189, impairs end resection, a commitment step in HR-mediated DSB repair. ATM is believed to be the chief mobilizer in initiating cellular response to DNA double-strand breaks. We demonstrate that, although BRCA1 is phosphorylated by ATM at multiple serine amino acid residues upon DSBs, the S1152A mutation in mouse BRCA1 is sufficient to decrease sustained ATM phosphorylation and activation. This suggests a previously unappreciated feedback loop between BRCA1 and ATM kinase activity, which in turn influences rate of end resection, presumably through its myriad of downstream substrates including MRE11 (<xref rid="bib26" ref-type="bibr">Virgilio et&#x000a0;al., 2009</xref>) (<xref rid="bib7" ref-type="bibr">Kijas et&#x000a0;al., 2015</xref>). We further show that this feedback loop is likely through the SKP2-NBS1-ATM circuit, whereby SKP2-ubiquitinated NBS1 at K63 enhances ATM recruitment and activation and reciprocally, subsequent NBS1 phosphorylation by ATM activates the downstream steps in DDR (<xref rid="bib28" ref-type="bibr">Wu et&#x000a0;al., 2000</xref>). Our results show that BRCA1-S1152A reduces BRCA1 interaction with SKP2 and its recruitment to DBS sites. Recruitment of NBS1 and phospho-ATM is also reduced while assembly of other repair proteins such as MRE11, CtIP, and 53BP1 is not affected.</p><p id="p0120">ATM is a master kinase for orchestrating global cellular responses to DSBs. In human, ATM intermolecular autophosphorylation on S1981 is a critical step in ATM kinase activation (<xref rid="bib2" ref-type="bibr">Bakkenist and Kastan, 2003</xref>). In addition, ATM autophosphorylation also occurs to other serine residues such as S367 and S1893 (<xref rid="bib11" ref-type="bibr">Kozlov et&#x000a0;al., 2006</xref>) (<xref rid="bib10" ref-type="bibr">Kozlov et&#x000a0;al., 2015</xref>) (<xref rid="bib12" ref-type="bibr">Lee and Paull, 2021</xref>). Interestingly, autophosphorylation of corresponding mouse ATM on S367, S1899, and S1987 did not seem to be required for mouse ATM activation in transgenic mouse models, in which transgenic expression of ATM-S1987A in <italic>Atm</italic> null mouse restored lymphocyte development and function (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>) (<xref rid="bib5" ref-type="bibr">Daniel et&#x000a0;al., 2008</xref>). Despite these findings, anti-human ATM-pS1981 antibody has been commonly used in literature as a readout for mouse ATM activation, under the assumption that autophosphorylation at ATM-S1987 is important for mouse ATM activation.</p><p id="p0125">In this study, we show that mouse ATM phosphorylation, as indicated by anti-human ATM-pS1981 antibody, indeed correlates with ATM kinase activity. However, our study of <italic>Atm</italic><sup><italic>S1987A/S1987A</italic></sup> KI MEF cells clearly demonstrates that the phosphorylation detected by this antibody is not related to mouse ATM-pS1987. This antibody therefore likely detects phosphorylation of other ATM serine residues involved in mouse ATM kinase activation, although the exact location of the phosphorylated serine residue(s) in ATM remains to be determined. Consistent with the behavior of previously reported <italic>Atm</italic> null cells (<xref rid="bib18" ref-type="bibr">Pellegrini et&#x000a0;al., 2006</xref>), the anti-human ATM-pS1981 antibody did not detect any signals in our ATM KO MEF cells. In addition, we show that ATM phosphorylation in response to &#x003b3;-IR was normal in two independent KI clones of <italic>Atm</italic><sup><italic>S1987A/S1987A</italic></sup> KI MEF cells, making it unlikely that other unknown mutations in the KI MEF clones caused cross reaction with the anti-human ATM-pS1981 antibody. Thus, our current data support the notion that ATM-S1987 is neither involved in mouse ATM kinase activation nor related to mouse ATM phosphorylation detected by anti-human ATM-pS1981 antibody. This helps clarify some of the confusing statements in current literature regarding mouse ATM-S1987.</p><p id="p0130">The impact of BRCA1 phosphorylation on ATM activation and recruitment seems unique to BRCA1-S1152, as BRCA1-S971A does not have the same effect on NBS1 and ATM. Our study therefore suggests that, although multiple phosphorylation sites on BRCA1 by various damage-activated kinases have ultimately promoted HR-mediated DNA repair, each phosphorylation event plays a distinct role in fine-tuning a particular step in the process. Collectively, these individual regulatory events ensure timing, accuracy, and efficiency of DSB repair. Our results also indicate that BRCA1 phosphorylation can influence other DNA repair-related proteins in a feedback loop, adding another layer of intricacy within DNA repair machinery. It is conceivable that communications mediated by phosphorylation and ubiquitination of different DNA repair proteins within the machinery ensures DNA repair to be conducted in an orderly and timely fashion.</p><sec id="sec3.1"><title>Limitations of the study</title><p id="p0135">Although the current study demonstrated that mouse ATM-S1987, which corresponds to human ATM-S1981, is not required for ATM phosphorylation and activity, we are not able to identify which serine amino acid in mouse ATM is detected by the antibody against human ATM-S1981P and is responsible for mouse ATM activity. More systematic research is needed in future to address this issue.</p></sec></sec><sec id="sec4"><title>STAR&#x02605;Methods</title><sec id="sec4.1"><title>Key resources table</title><p id="p0140">
<table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Chk1</td><td>Santa Cruz</td><td>sc-56291; RRID:AB_1121554</td></tr><tr><td>p-Chk1 (Ser345)</td><td>Cell Signaling</td><td>2348; RRID:AB_331212</td></tr><tr><td>RPA32</td><td>Santa Cruz</td><td>sc-28709; RRID:AB_2238546</td></tr><tr><td>p-RAP32/34 S4/S8</td><td>Bethyl Laboratories</td><td>A300-245A; RRID:AB_210547</td></tr><tr><td>CHK2</td><td>Cell Signaling</td><td>2662; RRID:AB_2080793</td></tr><tr><td>ATM</td><td>Thermo</td><td>MA5-14871; RRID:AB_10981520</td></tr><tr><td>p-ATM S1981</td><td>Rockland antibodies</td><td>200-301-400; RRID:AB_217868</td></tr><tr><td>H2A.X</td><td>Abcam</td><td>ab11175; RRID:AB_297814</td></tr><tr><td>&#x003b3;H2A.X (Ser139)</td><td>Millipore</td><td>05-636; :AB_309864</td></tr><tr><td>BRCA1</td><td>Calbiochem</td><td>OP-092;</td></tr><tr><td>CtIP</td><td>Cell signaling</td><td>9201; RRID:AB_10828593</td></tr><tr><td>p95/NBS1</td><td>Cell signaling</td><td>14956; RRID:AB_2798660</td></tr><tr><td>K63-linkage Specific Polyubiquitin</td><td>Cell signaling</td><td>5621; RRID:AB_10827985</td></tr><tr><td>SKP2</td><td>Cell signaling</td><td>2652; RRID:AB_11178941</td></tr><tr><td>RAD51</td><td>Santa Cruz</td><td>sc-8349; AB_2253533</td></tr><tr><td>&#x003b3;H2A.X</td><td>Cell signaling</td><td>9718; RRID:AB_2118009</td></tr><tr><td>BrdU</td><td>GE Life Sciences</td><td>RPN202; RRID:AB_2314032</td></tr><tr><td>BRCA1(287.17)</td><td>Santa Cruz</td><td>sc-135732; RRID:AB_2243740</td></tr><tr><td>CtIP</td><td>Millipore</td><td>RRID: MABE1060;</td></tr><tr><td>MRE11</td><td>Novus Biologicals</td><td>NB100-142; RRID:AB_10077796</td></tr><tr><td>SKP2</td><td>LSBio</td><td>LS-B2487; RRID:AB_2301745</td></tr><tr><td>53BP1</td><td>MAB3804</td><td>Millipore; RRID:AB_2256673</td></tr><tr><td>Alexa-488</td><td>Life Technologies</td><td>A11001; RRID:AB_2534069</td></tr><tr><td>Alexa -546</td><td>Life Technologies</td><td>A10036; RRID:AB_2757557</td></tr><tr><td>Alexa-568</td><td>Life Technologies</td><td>A11036; RRID:AB_10563566</td></tr><tr><td>p-H3 (Ser10)</td><td>Cell Signaling</td><td>9701s; RRID:AB_331535</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>BrdU (5-Bromo-2&#x02032;-deoxyuridine)</td><td>Millipore</td><td>19-160</td></tr><tr><td>DAPI</td><td>Vector Laboratories</td><td>H18002</td></tr><tr><td>RNase A</td><td>Roche</td><td>10109169001</td></tr><tr><td>Propidium Iodide</td><td>Sigma</td><td>P4864</td></tr><tr><td>NaCl</td><td>Fisher</td><td>BP358-2121</td></tr><tr><td>EDTA</td><td>Millipore</td><td>324504</td></tr><tr><td>NaF</td><td>Fisher</td><td>S299-100</td></tr><tr><td>Na<sub>3</sub>VO<sub>4</sub></td><td>Fisher</td><td>S454-50</td></tr><tr><td>Protease inhibitor cocktail</td><td>Cell Signaling</td><td>58725</td></tr><tr><td>Flag M2 magnetic beads</td><td>Sigma</td><td>M8823</td></tr><tr><td>RIPA buffer</td><td>Thermo</td><td>8990</td></tr><tr><td>Protein A/G plus agarose beads</td><td>Santa cruz</td><td>2003</td></tr><tr><td>cOmplete</td><td>Roche</td><td>30819700</td></tr><tr><td>Na<sub>4</sub>P<sub>2</sub>O<sub>7</sub>.10H<sub>2</sub>O</td><td>Fisher</td><td>S390</td></tr><tr><td>DTT</td><td>Sigma</td><td>D0632</td></tr><tr><td>SDS</td><td>Invitrogen</td><td>AM9820</td></tr><tr><td>Cas9</td><td>Trilink Bio Technologies</td><td>L-7606-100</td></tr><tr><td>Triton-X-100</td><td>Fisher</td><td>BP151</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Experimental models: Cell lines</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><italic>BRCA1</italic><sup><italic>+/+</italic></sup> MEF cells</td><td>This manuscript</td><td>N/A</td></tr><tr><td><italic>BRCA1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells</td><td>This manuscript</td><td>N/A</td></tr><tr><td>HEK293T</td><td>N/A</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Experimental models: Organisms/strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><italic>BRCA1</italic><sup><italic>+/S1152A</italic></sup> frozen mouse</td><td>NIH</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Oligonucleotides</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>sgRNA_#1 : AACAGTCCAACATTTGAAGA</td><td>This manuscript</td><td>N/A</td></tr><tr><td>sgRNA_#2 : ACATTTGAAGAAGGAGCTCA</td><td>This manuscript</td><td>N/A</td></tr><tr><td>sgRNA_#3 : TGAGCTCCTTCTTCAAATGT</td><td>This manuscript</td><td>N/A</td></tr><tr><td>sgRNA_#4 : GAAAAAAGTAAAGAAGAAAC</td><td>This manuscript</td><td>N/A</td></tr><tr><td>ATM_sq_6_F : CTGAGTTCTCGTCGCATTATTAC</td><td>This manuscript</td><td>N/A</td></tr><tr><td>ATM_S1987wt.R : CAAACTAGAAATAGTTGTTCCTTGACT</td><td>This manuscript</td><td>N/A</td></tr><tr><td>ATM_S1987A.R : CAAACTAGAAATAGTTGTTCCTTGAGC</td><td>This manuscript</td><td>N/A</td></tr><tr><td>ATM_sq_6_R: GACCTCTGGAAGAGCAGCTAG</td><td>This manuscript</td><td>N/A</td></tr><tr><td>ssODN sequence is: TAACATTGGATAGTATGTT<break/>CTCATTAAAAGAGATGTTTTTATGA<break/>TAAGCAGAAGTCCAACATTTGAAGA<break/>AGGAGCTCAAGGAACAACTATTTC<break/>TAGTTTGAGTGAAAAAAGTAAAGAAGA<break/>AACTGGAATAAGCTTACAGGTAAATATTAG.</td><td>This manuscript</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Recombinant DNA</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>pCDH1-mBRCA1</td><td>This manuscript</td><td>N/A</td></tr><tr><td>pCDH1-hBRCA1</td><td>This manuscript</td><td>N/A</td></tr><tr><td>pcDNA3-Flag</td><td>This manuscript</td><td>N/A</td></tr><tr><td>pcDNA3-Flag-BRCA1 (wt)</td><td>This manuscript</td><td>N/A</td></tr><tr><td>pcDNA3-Flag-BRCA1-S1189A</td><td>This manuscript</td><td>N/A</td></tr><tr><td>pcDNA3-Flag-BRCA1-S988A.</td><td>This manuscript</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Prism</td><td>GraphPad</td><td><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/" id="intref0010">https://www.graphpad.com/</ext-link></td></tr><tr><td>Fiji</td><td>Fiji</td><td><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji" id="intref0015">https://imagej.net/Fiji</ext-link></td></tr><tr><td>Flowjo</td><td>Flowjo</td><td><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/" id="intref0020">https://www.flowjo.com/</ext-link></td></tr><tr><td>Image Lab</td><td>Biorad</td><td><ext-link ext-link-type="uri" xlink:href="https://www.bio-rad.com" id="intref0025">https://www.bio-rad.com</ext-link></td></tr><tr><td>Biorender</td><td>Biorender</td><td><ext-link ext-link-type="uri" xlink:href="https://biorender.com/" id="intref0030">https://biorender.com/</ext-link></td></tr></tbody></table></table-wrap>
</p></sec><sec id="sec4.2"><title>Resource availability</title><sec id="sec4.2.1"><title>Lead contact</title><p id="p0145">Any request for resources or reagents should be directed to Yanfen Hu (<ext-link ext-link-type="uri" xlink:href="mailto:huy3@gwu.edu" id="intref0035">huy3@gwu.edu</ext-link>).</p></sec><sec id="sec4.2.2"><title>Materials availability</title><p id="p0150">All unique reagents generated in this study are available from the <xref rid="sec4.2.1" ref-type="sec">lead contact</xref> with a completed materials transfer agreement.</p></sec></sec><sec id="sec4.3"><title>Experimental model and subject details</title><sec id="sec4.3.1"><title>Animal housing and ethics</title><p id="p0155">All animal related experiments were approved by Institutional Animal Care and Use Committee (IACUC) at University of Texas Health San Antonio (2007&#x02013;2018) and The George Washington University (2018-present).</p></sec></sec><sec id="sec4.4"><title>Method details</title><sec id="sec4.4.1"><title>Generation of immortalized MEF cells</title><p id="p0160"><italic>BRCA1</italic><sup><italic>+/S1152A</italic></sup> frozen mouse embryos at 8-cell stage were obtained from NIH under specific MTA and frozen embryos were revived to give live mice and their genotype was confirmed. Mouse embryos (13.5&#x02013;14.5&#x000a0;days postcoitum) generated from intercrosses between <italic>BRCA1</italic><sup><italic>+/S1152A</italic></sup> mice were dissected and internal organs removed as described earlier (<xref rid="bib29" ref-type="bibr">Yang et&#x000a0;al., 2021</xref>). Genotyping of MEF cells was initially performed using residual embryo tissues and confirmed multiple times in the process of immortalization. WT and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells derived from littermate embryos were immortalized using the regular 3T3 protocol (<xref rid="bib25" ref-type="bibr">Todaro and Green, 1963</xref>).</p></sec><sec id="sec4.4.2"><title>Laser micro-irradiation</title><p id="p0165">In a standard laser microirradiation protocol, BrdU is incorporated in chromatin DNA before cells are subject to microirradiation (<xref rid="bib16" ref-type="bibr">Lukas et&#x000a0;al., 2003</xref>) (<xref rid="bib19" ref-type="bibr">Polo and Jackson, 2011</xref>). We made a minor modification of the protocol. i.e. we incubated MEF cells in the presence of BrdU only for two hours before microirradiation, rather than incubation with BrdU for overnight or 24-hours as commonly used in the field. The laser output was set at an energy level that DSBs could be generated only when DNA incorporated BrdU. In other words, microirradiation generated DSBs in a BrdU-dependent manner under this condition. This was confirmed and described in our previous work (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>), as demonstrated by the detection of gH2AX stripes, a readout for presence of DSBs, only when cells were preincubated with BrdU. Generation of DSBs by microirradiation in a BrdU-dependent manner, in combination with a transient 2-hours BrdU preincubation, ensures DSBs were generated only in the S/G2 cells even though the cells seeded were asynchronous. This design allowed us to conveniently examine accurate end resection kinetics in S/G2 cells, when end resection normally occurs, and effectively avoid generating DSBs in G1 cells, when end resection does not happen in principle.</p><p id="p0170">DSBs can also be generated by laser microirradiation in a BrdU-independent manner, when higher laser output is used (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). It is conceivable that BrdU-incorporated DNA might form less compacted DNA and therefore requires lower energy level to generate breaks. In contrast, normal DNA is densely compacted and needs higher laser energy to produce DSBs compared to BrdU-incorporated DNA. When DSBs are generated by BrdU-independent microirradiation, it is not necessary to pre-incubate cells in the presence of BrdU. Under this condition, every cell subject to microirradiation would produce DSB stripes, regardless whether DNA incorporated BrdU or not. In our BrdU-independent microirradiation, MEF cells were still preincubated with BrdU for 24 hours (same as in a standard microirradiation protocol) so that BrdU was incorporated into DNA in every cell. The purpose of BrdU incorporation in this context is to serve as a readout for end resection. The detection of BrdU by its antibodies in undenatured DNA reflects ongoing and/or completed end resection in these cells at DSBs.</p><p id="p0175">MEF cells were plated on 8-well Nunc Lab Tek II chamber slides and pre-treated with or without 50&#x000a0;&#x003bc;M BrdU for durations as indicated. Wells with &#x0223c;70&#x02013;80% cell confluency were chosen for micro-irradiation. Micro-irradiation was performed using a MMI Cell Cut laser micro-dissection system consisting of a 390&#x000a0;nm ND-YAG laser that is coupled to the optical path of a microscope. The details have been previously described (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>).</p></sec><sec id="sec4.4.3"><title>Immunofluorescence (IF</title><p id="p0180">Chamber slides were fixed at indicated times after micro-irradiation with either 3% paraformaldehyde/2% sucrose in phosphate buffer saline (PBS), pH 7.4 at room temperature (RT) for 15&#x000a0;min or 70% Methanol/30% Acetone at &#x02212;20&#x000b0;C for 15&#x000a0;min. Cells were washed and treated as previously described (<xref rid="bib17" ref-type="bibr">Parameswaran et&#x000a0;al., 2015</xref>). Primary antibodies were detected using specific secondary antibodies conjugated with Alexa-488 (1:1000 or 1:200), Alexa-546 (1:500) or Alexa-568 (1:200) (Molecular Probes, Life Technologies) at RT for 2&#x000a0;hours. Cells were then washed twice with 1XPBS at RT for 5&#x000a0;min and were mounted with a 24&#x000a0;&#x000d7;&#x000a0;50, #1.5 coverslip using Vectashield with DAPI (Vector Laboratories). All immunostained slides were visualized using Zeiss LSM710 confocal microscope.</p></sec><sec id="sec4.4.4"><title>Imaging</title><p id="p0185">ImageJ software was used for the purpose of laser stripe intensity quantification. Straight line tool (line width&#x000a0;= 20) was used to draw lines over all &#x003b3;H2AX stripes and the intensities of corresponding BRCA1 stripes were measured.</p></sec><sec id="sec4.4.5"><title>Cell cycle distribution by flow cytometry</title><p id="p0190">For BrdU/PI labeling, <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells were pulse-labeled with 50&#x000a0;&#x003bc;M BrdU for 1&#x000a0;hour. After trypsinization, cells were washed in 1XPBS containing 1%FBS and 1% Sodium azide (PBS/S/N), then fixed in pre-chilled 90% ethanol, followed by washing in PBS/S/N solution to remove ethanol. Cells were then treated with 2M HCl and incubated at RT for 20&#x000a0;min, washed in wash buffer (PBS/0.5% Tween-20/0.5% BSA) followed by neutralization with 0.1M Boric Acid, pH 8.5 at RT for 5&#x000a0;min. Cells were washed and then stained with Alexa Fluor- 488 conjugated anti-BrdU (1:100, GE Healthcare) at 37&#x000b0;C for 30&#x000a0;min in the dark. Cells were then washed and incubated in PBS containing 25&#x003bc;g/mL Propidium Iodide (Sigma) and 25&#x003bc;g/mL RNase A (Roche) at RT for 30&#x000a0;min followed by flow cytometric analysis.</p><p id="p0195">For detection of phosphorylated histone H3ser10, ethanol-fixed cells were permeabilized with 0.25% Triton-X-100 in PBS on ice for 15&#x000a0;min, washed and stained with anti-phospho-Ser10 histone H3 antibody (1:50, Cell Signaling Technology) for 1 hour at 37&#x000b0;C. This was followed by incubation of Alexa Fluor 488-conjugated anti-rabbit secondary antibody (1:500, Molecular Probes) at 37&#x000b0;C for 1 hour in the dark. Cells were washed and incubated with PI for 30&#x000a0;min prior to flow cytometry analysis. All data were collected using FACS Calibur (Becton Dickson) and analyzed using Flowjo software.</p></sec><sec id="sec4.4.6"><title>Co-immunoprecipitation (Co-IP) in HEK293T cells</title><p id="p0200">HEK293T cells (2&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/6-cm dish) were transfected with pcDNA3-Flag (vector control), pcDNA3-Flag-BRCA1 (wt), pcDNA3-Flag-BRCA1-S1189A or pcDNA3-Flag-BRCA1-S988A. 24&#x000a0;h post-transfection, cells from one 6-cm dish were split into two 10-cm dishes. 24&#x000a0;h post re-seeding, one of the two plates was subjected to 20Gy IR. Cells were incubated at 37&#x000b0;C for 30&#x000a0;min before harvesting. Cells were lysed by rotating at 4&#x000b0;C for 30&#x000a0;min in 500&#x000a0;&#x003bc;L of NETN lysis buffer (150&#x000a0;mM NaCl, 1&#x000a0;mM EDTA, 20&#x000a0;mM Tris HCl, pH 8.0, 0.5% NP-40, 5&#x000a0;mM NaF, 2&#x000a0;mM Na<sub>4</sub>P<sub>2</sub>O<sub>7</sub>.10H<sub>2</sub>O, 2&#x000a0;mM Na<sub>3</sub>VO<sub>4</sub>, 1&#x000a0;mM PMSF, cOmplete, Mini, EDTA-free Protease inhibitor cocktail from Roche)). Lysed cells were passed through 21G needle 10&#x02013;12 times, and then clarified by centrifugation at 14,000&#x000a0;rpm for 10&#x000a0;min at 4&#x000b0;C. Protein quantification using BCA kit (following the company protocol) was performed and approximately 600&#x000a0;&#x003bc;g of lysate was used for IP with anti-Flag M2 magnetic beads (#M8823, Sigma). The samples were then resolved by SDS-PAGE followed by immunoblotting.</p></sec><sec id="sec4.4.7"><title>Immunoprecipitation in MEF cells</title><p id="p0205"><italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells (6&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells each) and <italic>Brca1</italic><sup><italic>WT</italic></sup> and <italic>Brca1</italic><sup><italic>S971A/S971A</italic></sup> MEF cells (6&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells each) were subjected to no IR or 10&#x000a0;Gy IR and incubated at 37&#x000b0;C for 1 hour before harvesting. Cell pellets were lysed in 500&#x02013;1000&#x000a0;&#x003bc;L RIPA buffer and lysates were passed through 21G needle 10&#x02013;12 times and were clarified by centrifugation at 14,000&#x000a0;rpm for 10&#x000a0;min. Protein quantification using Pierce BCA kit was performed per the manufacturer&#x02019;s protocol and approximately 1000&#x02013;1500&#x000a0;&#x003bc;g of sample was precleared with 20&#x000a0;&#x003bc;L Protein A/G plus agarose beads (#2003, Santa cruz) at 4&#x000b0;C for 30&#x000a0;min and IP&#x02019;ed with anti-p95/NBS1 (D6J51)or irrelevant anti-rabbit antibody as a control. On following day, 20&#x000a0;&#x003bc;L of Protein A/G plus agarose beads were added and allowed to combine at 4&#x000b0;C for 4 h. Samples were resolved by SDS-PAGE followed by immunoblotting.</p></sec><sec id="sec4.4.8"><title>Immunoblotting</title><p id="p0210">Following experimental conditions, cells were lysed in 2X Laemmli buffer (100&#x000a0;mM Tris pH6.8, 200&#x000a0;mM DTT, 4% SDS, 20% glycerol, 0.2% BPB) and boiled for 10&#x000a0;min. Samples were resolved in 5&#x02013;15% SDS-PAGE and electrophoretically transferred into nitrocellulose or polyvinylidene difluoride (PVDF) (for ATM blots) membranes. Membranes were blocked in 5% milk-TBST and probed with primary antibodies described in the table below.</p></sec><sec id="sec4.4.9"><title>Generation of ATM-S1987A knock-in (KI) and knock-out (KO) MEFs using CRISPR/Cas9 genome editing system in wild type MEF</title><p id="p0215">Four sgRNA oligos for generating DSBs in <italic>Atm</italic> gene locus around ATM-S1987 position were designed and selected from the Benching or Broad Institute platform. Two million wild type MEF cells were transfected with sgRNA (12&#x000a0;&#x003bc;g), Cas9 (20&#x000a0;&#x003bc;g, Trilink Bio Technologies, L-7606), ssODN (single-stranded oligodeoxynucleotides as the template in HR mediated repair process, 26&#x000a0;&#x003bc;g, IDT) mixture using Nucleofector 2b following the Nucleofector kit (Lonza, VPD-1005) protocol. Cells were re-seeded in 96-well plates (0.8 cell/well) one day after transfection and single-cell clones were screened for desired KI and KO at <italic>ATM</italic> locus. All KI or KO clones were screened by PCR first (using primers ATM_sq_6_F with either ATM_S1987 wt.R or ATM_S1987A.R) and then confirmed by sequencing (GENEWIZ, PCR primer used for this step is ATM_sq_6_F and ATM_sq_6_R.</p></sec><sec id="sec4.4.10"><title>Generation of <italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF stably expressing full-length wild type human BRCA1 or mouse BRCA1</title><p id="p0220"><italic>Brca1</italic><sup><italic>S1152A/S1152A</italic></sup> MEF cells were transfected with either pCDH1-hBRCA1 or pCDH1-mBRCA1 following the Nucleofector kit protocol (Lonza, VPD-1005) and selected by Puromycin (Gibco, A1113803) 2&#x000a0;days after transfection. Overexpression of exogenous full-length BRCA1 in pooled cells was examined and confirmed by BRCA1 Western blotting.</p></sec></sec><sec id="sec4.5"><title>Quantification and statistical analysis</title><p id="p0225">Each graph is quantification of several independent experiments, acquired either on different days or performed by different scientists as indicated in the figure legends. All statistical analyses were performed using Microsoft Excel. Unpaired students t-test was performed to generate p values indicative of statistical significance. p-value: No significance (ns); p&#x0003c;0.05 (&#x02217;); p&#x0003c;0.01 (&#x02217;&#x02217;); p&#x0003c;0.001 (&#x02217;&#x02217;&#x02217;).</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Abdulkarim</surname><given-names>B.S.</given-names></name><name><surname>Cuartero</surname><given-names>J.</given-names></name><name><surname>Hanson</surname><given-names>J.</given-names></name><name><surname>Desche&#x002c6;nes</surname><given-names>J.</given-names></name><name><surname>Lesniak</surname><given-names>D.</given-names></name><name><surname>Sabri</surname><given-names>S.</given-names></name></person-group><article-title>Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy</article-title><source>J.&#x000a0;Clin. Oncol.</source><volume>29</volume><year>2011</year><fpage>2852</fpage><lpage>2858</lpage><ext-link ext-link-type="uri" xlink:href="http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2010.33.4714" id="intref0045">http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2010.33.4714</ext-link><pub-id pub-id-type="pmid">21670451</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Bakkenist</surname><given-names>C.J.</given-names></name><name><surname>Kastan</surname><given-names>M.B.</given-names></name></person-group><article-title>DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation</article-title><source>Nature</source><volume>421</volume><year>2003</year><fpage>499</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">12556884</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Blackford</surname><given-names>A.N.</given-names></name><name><surname>Jackson</surname><given-names>S.P.</given-names></name></person-group><article-title>ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response</article-title><source>Mol. Cell</source><volume>66</volume><year>2017</year><fpage>801</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">28622525</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Cortez</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Elledge</surname><given-names>S.J.</given-names></name></person-group><article-title>Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks</article-title><source>Science</source><volume>286</volume><year>1999</year><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">10550055</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>J.A.</given-names></name><name><surname>Pellegrini</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Paull</surname><given-names>T.T.</given-names></name><name><surname>Feigenbaum</surname><given-names>L.</given-names></name><name><surname>Nussenzweig</surname><given-names>A.</given-names></name></person-group><article-title>Multiple autophosphorylation sites are dispensable for murine ATM activation in&#x000a0;vivo</article-title><source>J.&#x000a0;Cell Biol.</source><volume>183</volume><year>2008</year><fpage>777</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">19047460</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Huen</surname><given-names>M.S.Y.</given-names></name><name><surname>Sy</surname><given-names>S.M.H.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>BRCA1 and its toolbox for the maintenance of genome integrity</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>11</volume><year>2010</year><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/nrm2831</pub-id><pub-id pub-id-type="pmid">20029420</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Kijas</surname><given-names>A.W.</given-names></name><name><surname>Lim</surname><given-names>Y.C.</given-names></name><name><surname>Bolderson</surname><given-names>E.</given-names></name><name><surname>Cerosaletti</surname><given-names>K.</given-names></name><name><surname>Gatei</surname><given-names>M.</given-names></name><name><surname>Jakob</surname><given-names>B.</given-names></name><name><surname>Tobias</surname><given-names>F.</given-names></name><name><surname>Taucher-Scholz</surname><given-names>G.</given-names></name><name><surname>Gueven</surname><given-names>N.</given-names></name><name><surname>Oakley</surname><given-names>G.</given-names></name><etal/></person-group><article-title>ATM-dependent phosphorylation of MRE11 controls extent of resection during homology directed repair by signalling through Exonuclease 1</article-title><source>Nucleic Acids Res.</source><volume>43</volume><year>2015</year><fpage>8352</fpage><lpage>8367</lpage><pub-id pub-id-type="pmid">26240375</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Baek</surname><given-names>H.J.</given-names></name><name><surname>Lim</surname><given-names>S.-C.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>R.-H.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Cho</surname><given-names>K.H.</given-names></name><name><surname>Deng</surname><given-names>C.-X.</given-names></name></person-group><article-title>Impaired skin and mammary gland development and increased r-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1</article-title><source>Cancer Res.</source><volume>69</volume><year>2009</year><fpage>9291</fpage><lpage>9300</lpage><pub-id pub-id-type="pmid">19996295</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Huber</surname><given-names>L.J.</given-names></name><name><surname>Chodosh</surname><given-names>L.A.</given-names></name><name><surname>Deng</surname><given-names>C.-X.</given-names></name></person-group><article-title>Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1</article-title><source>Mol. Cell Biol.</source><volume>24</volume><year>2004</year><fpage>9498</fpage><lpage>9507</lpage><pub-id pub-id-type="pmid">15485917</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Kozlov</surname><given-names>S.V.</given-names></name><name><surname>Graham</surname><given-names>M.E.</given-names></name><name><surname>Jakob</surname><given-names>B.</given-names></name><name><surname>Tobias</surname><given-names>F.</given-names></name><name><surname>Kijas</surname><given-names>A.W.</given-names></name><name><surname>Tanuji</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Robinson</surname><given-names>P.J.</given-names></name><name><surname>Taucher-Scholz</surname><given-names>G.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Autophosphorylation and ATM activation</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>286</volume><year>2015</year><fpage>9107</fpage><lpage>9119</lpage></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Kozlov</surname><given-names>S.V.</given-names></name><name><surname>Graham</surname><given-names>M.E.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Robinson</surname><given-names>P.J.</given-names></name><name><surname>Lavin</surname><given-names>M.F.</given-names></name></person-group><article-title>Involvement of novel autophosphorylation sites in ATM activation</article-title><source>EMBO J.</source><volume>25</volume><year>2006</year><fpage>3504</fpage><lpage>3514</lpage><pub-id pub-id-type="pmid">16858402</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Paull</surname><given-names>T.T.</given-names></name></person-group><article-title>Cellular functions of the protein kinase ATM and their relevance to human disease</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>22</volume><year>2021</year><fpage>796</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">34429537</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-S.</given-names></name><name><surname>Collins</surname><given-names>K.M.</given-names></name><name><surname>Brown</surname><given-names>A.L.</given-names></name><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Chung</surname><given-names>J.H.</given-names></name></person-group><article-title>hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response</article-title><source>Nature</source><volume>404</volume><year>2000</year><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">10724175</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.C.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Z.-C.</given-names></name><name><surname>Wu</surname><given-names>G.-Z.</given-names></name><name><surname>Cui</surname><given-names>S.-S.</given-names></name><name><surname>Tan</surname><given-names>E.K.</given-names></name><name><surname>Zeng</surname><given-names>L.</given-names></name></person-group><article-title>Ribosomal S6 kinase 2 (RSK2) maintains genomic stability by activating the atm/p53-dependent DNA damage pathway</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><fpage>e74334</fpage><pub-id pub-id-type="pmid">24086335</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>D.</given-names></name><name><surname>Parameswaran</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Yew</surname><given-names>P.R.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>287</volume><year>2012</year><fpage>41014</fpage><lpage>41022</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.407106</pub-id><pub-id pub-id-type="pmid">23086937</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Lukas</surname><given-names>C.</given-names></name><name><surname>Falck</surname><given-names>J.</given-names></name><name><surname>Bartkova</surname><given-names>J.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name></person-group><article-title>Distinct spatiotemporal dynamics of mammallian checkpoint regulators induced by DNA damage</article-title><source>Nat. Cell Biol.</source><volume>5</volume><year>2003</year><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">12598907</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Parameswaran</surname><given-names>B.</given-names></name><name><surname>Chiang</surname><given-names>H.C.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Coates</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>C.X.</given-names></name><name><surname>Baer</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>H.K.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Paull</surname><given-names>T.T.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection</article-title><source>Cell Cycle</source><volume>14</volume><year>2015</year><fpage>437</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">25659039</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>M.</given-names></name><name><surname>Celeste</surname><given-names>A.</given-names></name><name><surname>Difilippantonio</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Feigenbaum</surname><given-names>L.</given-names></name><name><surname>Nussenzweig</surname><given-names>A.</given-names></name></person-group><article-title>Autophosphorylation at serine 1987 is dispensable for murine Atm activation in&#x000a0;vivo</article-title><source>Nature</source><volume>443</volume><year>2006</year><fpage>222</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16906133</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Polo</surname><given-names>S.E.</given-names></name><name><surname>Jackson</surname><given-names>S.P.</given-names></name></person-group><article-title>Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications</article-title><source>Genes Dev.</source><volume>25</volume><year>2011</year><fpage>409</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">21363960</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ochs</surname><given-names>R.L.</given-names></name><name><surname>Keegan</surname><given-names>K.</given-names></name><name><surname>Hoekstra</surname><given-names>M.</given-names></name><name><surname>Feunteun</surname><given-names>J.</given-names></name><name><surname>Livingston</surname><given-names>D.M.</given-names></name></person-group><article-title>Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage</article-title><source>Cell</source><volume>90</volume><year>1997</year><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">9267023</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Plug</surname><given-names>A.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Weaver</surname><given-names>D.</given-names></name><name><surname>Feunteun</surname><given-names>J.</given-names></name><name><surname>Ashley</surname><given-names>T.</given-names></name><name><surname>Livingston</surname><given-names>D.M.</given-names></name></person-group><article-title>Association of BRCA1 with Rad51 in mitotic and meiotic cells</article-title><source>Cell</source><volume>88</volume><year>1997</year><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">9008167</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Shiloh</surname><given-names>Y.</given-names></name><name><surname>Ziv</surname><given-names>Y.</given-names></name></person-group><article-title>The ATM protein kinase: regulating the cellular response to genotoxic stress, and more</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>14</volume><year>2013</year><fpage>197</fpage><lpage>210</lpage></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Stracker</surname><given-names>T.H.</given-names></name><name><surname>Morales</surname><given-names>M.</given-names></name><name><surname>Couto</surname><given-names>S.S.</given-names></name><name><surname>Hussein</surname><given-names>H.</given-names></name><name><surname>Petrini</surname><given-names>J.H.J.</given-names></name></person-group><article-title>The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex</article-title><source>Nature</source><volume>447</volume><year>2007</year><fpage>218</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">17429352</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Mao</surname><given-names>Z.</given-names></name></person-group><article-title>Phosphorylation of ATM by Cdk5 mediates DNA damage signaling and regulates neuronal death</article-title><source>Nat. Cell Biol.</source><volume>11</volume><year>2009</year><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">19151707</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Todaro</surname><given-names>G.J.</given-names></name><name><surname>Green</surname><given-names>H.</given-names></name></person-group><article-title>Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines</article-title><source>J.&#x000a0;Cell Biol.</source><volume>17</volume><year>1963</year><fpage>299</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">13985244</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Virgilio</surname><given-names>M.</given-names></name><name><surname>Ying</surname><given-names>C.Y.</given-names></name><name><surname>Gautier</surname><given-names>J.</given-names></name></person-group><article-title>PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin</article-title><source>DNA Repair</source><volume>8</volume><year>2009</year><fpage>1311</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">19709933</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>C.-Y.</given-names></name><name><surname>Rezaeian</surname><given-names>A.H.</given-names></name><name><surname>Chan</surname><given-names>C.-H.</given-names></name><name><surname>Li</surname><given-names>J.-M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1</article-title><source>Mol. Cell</source><volume>46</volume><year>2012</year><fpage>351</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">22464731</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Ranganathan</surname><given-names>V.</given-names></name><name><surname>Weisman</surname><given-names>D.S.</given-names></name><name><surname>Heine</surname><given-names>W.F.</given-names></name><name><surname>Ciccone</surname><given-names>D.N.</given-names></name><name><surname>O'Neill</surname><given-names>T.B.</given-names></name><name><surname>Crick</surname><given-names>K.E.</given-names></name><name><surname>Pierce</surname><given-names>K.A.</given-names></name><name><surname>Lane</surname><given-names>W.S.</given-names></name><name><surname>Rathbun</surname><given-names>G.</given-names></name><etal/></person-group><article-title>ATM phosphorylation of Nijmegan breakage syndrome protein is required in a DNA damage response</article-title><source>Nature</source><volume>405</volume><year>2000</year><fpage>477</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">10839545</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Qi</surname><given-names>L.</given-names></name><name><surname>Chiang</surname><given-names>H.-C.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>BRCA1 antibodies matter</article-title><source>Int. J. Biol. Sci.</source><volume>17</volume><year>2021</year><fpage>3239</fpage><lpage>3254</lpage><pub-id pub-id-type="pmid">34421362</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Powell</surname><given-names>S.N.</given-names></name></person-group><article-title>The role of the BRCA1 tumor suppressor in DNA double-strand break repair</article-title><source>Mol. Cancer Res.</source><volume>3</volume><year>2005</year><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-05-0192</pub-id><pub-id pub-id-type="pmid">16254187</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Willers</surname><given-names>H.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Ghosh</surname><given-names>J.C.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Weaver</surname><given-names>D.T.</given-names></name><name><surname>Chung</surname><given-names>J.H.</given-names></name><name><surname>Powell</surname><given-names>S.N.</given-names></name><name><surname>Xia</surname><given-names>F.</given-names></name></person-group><article-title>Chk2-phosphorylation of BRCA1 regulates DNA double-strand break repair</article-title><source>Mol. Cell Biol.</source><volume>24</volume><year>2004</year><fpage>708</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">14701743</pub-id></element-citation></ref></ref-list><sec id="appsec2" sec-type="supplementary-material"><title>Supplemental information</title><p id="p0250">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figure&#x000a0;S1</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p></sec><sec sec-type="data-availability" id="da0010"><title>Data and code availability</title><p id="p0025">All data reported in this paper will be shared by the <xref rid="sec4.2.1" ref-type="sec">lead contact</xref> upon request. This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the <xref rid="sec4.2.1" ref-type="sec">lead contact</xref> upon request.</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0230">We thank Paula Garza and Sabrina Smith for reviving <italic>Brca1</italic><sup><italic>+/S1152A</italic></sup> frozen embryos and isolating primary MEFs. We appreciate Huai-Chin Chiang and Haihui Pan for helpful technical input. All animal-related experiments were approved by Institutional Animal Care and Use Committee (IACUC) at the George Washington University (GWU) and University of Texas Health San Antonio (UTHSCSA, where the work was initially performed). This work was supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> (R01CA212674 to YH and R01CA220578 to RL]).</p><sec id="sec5"><title>Author contributions</title><p id="p0235">L.Q. and R.C. were responsible for designing and conducting most of the research described in this manuscript. M.L. was responsible for designing and constructing human BRCA1 constructs. C.D. generated BRCA1 KI mouse and was involved in initial discussion of the project. R.L. and Y.H. were responsible for overall design of the project, supervising the project, data analysis, and drafting manuscript.</p></sec><sec sec-type="COI-statement" id="sec6"><title>Declaration of interests</title><p id="p0240">The authors declare no competing financial interests.</p></sec></ack><fn-group><fn id="appsec1" fn-type="supplementary-material"><p id="p0245">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2022.104944" id="intref0040">https://doi.org/10.1016/j.isci.2022.104944</ext-link>.</p></fn></fn-group></back></article>
